BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 23
• 26
• 27
• 28
• 29
• 30

• Policy

  Noden Pharma Notified Of ANDA Filing For Tekturna

  June 5, 2017

   · 

  2 min read
• Drug Development

  AbbVie Release: New Data Presented At ASCO 2017 Finds IMBRUVICA (Ibrutinib) May Offer A More Targeted Approach To Chronic Lymphocytic Leukemia (CLL) Treatment Than Chemotherapy Agent Chlorambucil In Treatment-Naïve Patients

  June 5, 2017

   · 

  14 min read
• Drug Development

  Bird Rock Bio Completes Single Ascending Dose Human Clinical Trial For Namacizumab; Generates Safety, Tolerability, And Pharmacokinetics Data; Prepares To Initiate Study In Non-Alcoholic Fatty Liver Disease Patients

  June 5, 2017

   · 

  3 min read
• Drug Development

  Kite Pharma Reports 73 Percent Of Patients Achieved MRD Negative Complete Remission In Updated Analysis From Phase I ZUMA-3 CAR-T Trial Of KTE-C19 In Adult Patients With High Burden Relapsed/Refractory Acute Lymphoblastic Leukemia

  June 5, 2017

   · 

  4 min read
• Business

  PRANA Biotechnology Appoints David Stamler As Chief Medical Officer To Lead Clinical Development

  June 5, 2017

   · 

  2 min read
• BioMidwest

  Invitae Release: ASCO Data Shows Prostate Cancer Patients With Genetic Risk Factors Missed Under Current Testing Guidelines

  June 5, 2017

   · 

  5 min read
• Drug Development

  Compugen Ltd. Presents At ASCO COM701 Drug Combination Data With TIGIT And PD-1 Inhibitors In Preclinical Models

  June 5, 2017

   · 

  6 min read
• Drug Development

  Bristol-Myers Squibb New Data Evaluating The Safety And Preliminary Relapse-Free Survival Of Adjuvant Yervoy (Ipilimumab) 3 Mg/Kg And 10 Mg/Kg In Resected High-Risk Melanoma Patients Presented At ASCO

  June 5, 2017

   · 

  2 min read
• BioMidwest

  Ampio Pharmaceuticals, Inc. Announces Pricing of Registered Direct Offering

  June 5, 2017

   · 

  3 min read
• Drug Development

  Celltrion Healthcare Biosimilar Trastuzumab Candidate, CT-P6, Shown To Be Similar In Efficacy And Safety To The Reference Trastuzumab

  June 5, 2017

   · 

  4 min read